Corrigendum to "Dihydroartemisin inhibits glioma invasiveness via a ROS to P53 to β-catenin signaling" [Pharmacol. Res. 119 (2017) 72-88]

Affiliations

• ¹ Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang 110004, People's Republic of China; Liaoning Research Center for Translational Medicine in Nervous System Disease, Shenyang 110004, People's Republic of China.
• ² Department of Neurobiology, College of Basic Medicine, China Medical University, Shenyang 110122, People's Republic of China.
• ³ Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang 110004, People's Republic of China; Liaoning Research Center for Translational Medicine in Nervous System Disease, Shenyang 110004, People's Republic of China. Electronic address: [email protected].